Detection of myocardial viability by contrast echocardiography in acute infarction predicts recovery of resting function and contractile reserve.

[1]  Hisashi Masugata,et al.  Contrast echocardiography can assess risk area and infarct size during coronary occlusion and reperfusion: experimental validation. , 2002, Journal of the American College of Cardiology.

[2]  A. Schömig,et al.  Myocardial blood volume and the amount of viable myocardium early after mechanical reperfusion of acute myocardial infarction: prospective study using venous contrast echocardiography , 2002, Heart.

[3]  S. Kaul,et al.  Noninvasive Prediction of Ultimate Infarct Size at the Time of Acute Coronary Occlusion Based on the Extent and Magnitude of Collateral-Derived Myocardial Blood Flow , 2001, Circulation.

[4]  A. Magalski,et al.  Full-motion pulse inversion power Doppler contrast echocardiography differentiates stunning from necrosis and predicts recovery of left ventricular function after acute myocardial infarction. , 2001, Journal of the American College of Cardiology.

[5]  G. Stone,et al.  Normal Flow (TIMI-3) Before Mechanical Reperfusion Therapy Is an Independent Determinant of Survival in Acute Myocardial Infarction: Analysis From the Primary Angioplasty in Myocardial Infarction Trials , 2001, Circulation.

[6]  O. Kamp,et al.  Serial evaluation of perfusion defects in patients with a first acute myocardial infarction referred for primary PTCA using intravenous myocardial contrast echocardiography. , 2001, European heart journal.

[7]  R. Senior,et al.  Intravenous myocardial contrast echocardiography predicts recovery of dysynergic myocardium early after acute myocardial infarction. , 2001, Journal of the American College of Cardiology.

[8]  C. Visser,et al.  Assessment of Myocardial Reperfusion by Intravenous Myocardial Contrast Echocardiography and Coronary Flow Reserve After Primary Percutaneous Transluminal Coronary Angiography in Patients With Acute Myocardial Infarction , 2000 .

[9]  J Sklenar,et al.  Assessment of resting perfusion with myocardial contrast echocardiography: theoretical and practical considerations. , 2000, American heart journal.

[10]  U. Deligonul,et al.  The clinical implications of no reflow demonstrated with intravenous perfluorocarbon containing microbubbles following restoration of Thrombolysis In Myocardial Infarction (TIMI) 3 flow in patients with acute myocardial infarction. , 1998, The American journal of cardiology.

[11]  J. Oh,et al.  Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction. , 1998, Journal of the American College of Cardiology.

[12]  A R Jayaweera,et al.  Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. , 1998, Circulation.

[13]  D. Antoniucci,et al.  Influence of infarct-zone viability on left ventricular remodeling after acute myocardial infarction. , 1997, Circulation.

[14]  W. Zoghbi,et al.  Serial changes in response of hibernating myocardium to inotropic stimulation after revascularization: a dobutamine echocardiographic study. , 1997, Journal of the American College of Cardiology.

[15]  T. Sakuma,et al.  Usefulness of myocardial contrast echocardiography for the assessment of serial changes in risk area in patients with acute myocardial infarction. , 1996, The American journal of cardiology.

[16]  Y. Taniyama,et al.  Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. , 1996, Circulation.

[17]  M. Hori,et al.  Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. , 1996, Circulation.

[18]  R. Senior,et al.  Technetium 99m-labeled sestamibi imaging reliably identifies retained contractile reserve in dyssynergic myocardial segments , 1995, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[19]  S. Kaul,et al.  Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction. New insights using myocardial contrast echocardiography. , 1994, Circulation.

[20]  S. Kaul,et al.  Characterization of Spatial Patterns of Flow Within the Reperfused Myocardium by Myocardial Contrast Echocardiography Implications in Determining Extent of Myocardial Salvage , 1993, Circulation.

[21]  S. Kaul,et al.  Assessment of Risk Area During Coronary Occlusion and Infarct Size After Reperfusion With Myocardial Contrast Echocardiography Using Left and Right Atrial Injections of Contrast , 1993, Circulation.

[22]  A. Kitabatake,et al.  Lack of Myocardial Perfusion Immediately After Successful Thrombolysis: A Predictor of Poor Recovery of Left Ventricular Function in Anterior Myocardial Infarction , 1992, Circulation.

[23]  Dwight E. Peake,et al.  Thrombolysis in myocardial infarction (TIMI) trial: Phase I. A comparison between intravenous tissue plasminogen activator and intravenous streptokinase , 1988 .

[24]  R Roberts,et al.  Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. , 1987, Circulation.

[25]  A J Buda,et al.  Direct measurement of inner and outer wall thickening dynamics with epicardial echocardiography. , 1986, Circulation.

[26]  G. Hutchins,et al.  Infarct expansion: pathologic analysis of 204 patients with a single myocardial infarct. , 1986, Journal of the American College of Cardiology.

[27]  G M Hutchins,et al.  Two‐dimensional Echocardiography and Infarct Size: Relationship of Regional Wall Motion and Thickening to the Extent of Myocardial Infarction in the Dog , 1981, Circulation.

[28]  A. Jaffe,et al.  Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. , 1988, Journal of the American College of Cardiology.

[29]  Harold T. Dodge,et al.  Thrombolysis inMyocardial Infarction (TIMI) Trial, Phase I:acomparison between intravenous tissue plasminogen activator andintravenous streptokinase* , 1987 .

[30]  Mitsuyoshi Hagio,et al.  Two-Dimensional Echocardiography in the Dog , 1985 .